Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Адс Терапьютикс Са, Медимьюн ЛимитедfiledCriticalАдс Терапьютикс Са
Priority claimed from PCT/EP2018/065873external-prioritypatent/WO2018229222A1/en
Publication of EA202190041A1publicationCriticalpatent/EA202190041A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Настоящее изобретение относится к лечению патологических состояний, таких как рак, с применением конъюгатов антитело-лекарственное средство (ADC). В частности, настоящее изобретение относится к введению ADC, которые связываются с CD19 (CD19-ADC).The present invention relates to the treatment of pathological conditions such as cancer using antibody-drug conjugates (ADCs). In particular, the present invention relates to the administration of ADCs that bind to CD19 (CD19-ADC).
EA202190041A2018-05-232018-06-14
DOSING SCHEDULES FOR ADC K CD19 ADMINISTRATION
EA202190041A1
(en)